The Circle of Trust is a new conceptual model that can help investigators and the American Indian/Alaska Natives (AI/AN) community work together to promote inclusion of AI/AN populations in clinical trials to improve health outcomes....
With today’s well-known workforce challenges, it is more important than ever for sites to address workforce development in a meaningful way, reimagining how clinical research departments perform in an organizational context....
National Institutes of Health (NIH) representatives state that international investment, collaboration, and coordination have been key to responding to the COVID-19 pandemic....
As the first generation of Alzheimer's disease drugs hits the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people. ...
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna’s investigational mRNA vaccine for respiratory syncytial virus (RSV) in adult patients....
National Cancer Institute reviewers found that the UW Carbone Cancer Center’s six program areas were rated 'outstanding' or 'outstanding to exceptional'....
Predictive analytics, the use of data, algorithms and visualizations to forecast outcomes, is being increasingly used in drug development and clinical trial design....
The NIH explores ways to speed up the research and discovery of new treatments for rare diseases, which are not often thought of as the public health challenge that they are. ...
Following a year filled with several approvals for rare disease drugs, experts are expecting this trend to continue in 2023....
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
